Gerald J. Duke

Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering

Tracy Mitchell, Doree Sitkoff, Fred Lo et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 132 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Structural basis for CARM1 inhibition by indole and pyrazole inhibitors

John S. Sack, Sandrine Thieffine, Tiziano Bandiera et al. · Biochemical Journal · 2011 · 97 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +12

Effects of the Prosegment and pH on the Activity of PCSK9

Suzanne Benjannet, Yascara Grisel Luna Saavedra, Josée Hamelin et al. · Journal of Biological Chemistry · 2010 · 65 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors

Stephen T. Wrobleski, Shuqun Lin, John Hynes et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Triazolopyrimidines identified as reversible myeloperoxidase inhibitors

Franck Duclos, Lynn M. Abell, David Harden et al. · MedChemComm · 2017 · 29 citations

Life Sciences, Immunology, Pharmacology +16